PQRS Individual Quality Measures

All PQRS individual quality measures can be reported with the MDinteractive registry. The PQRS address various aspects of care, such as prevention, chronic- and acute-care management, procedure-related care, resource utilization, and care coordination.
Measure selection begins with a review of the 2011 PQRI Measures List to determine which measures may be of interest to the practice. The list is available at the CMS PQRS website or at the AMA website. You also can check the PQRS Release Notes in order to find out what changed in 2011 for each individual measure.
The following factors should be considered when selecting measures for reporting:
• Clinical conditions usually treated
• Types of care typically provided – e.g., preventive, chronic, acute
• Settings where care is usually delivered – e.g., office, ED, surgical suite
• Quality improvement goals for 2011
Each provider will need to submit data on ≥ 80% of applicable Medicare patients on at least 3 individual measures in order to be eligible for the 1% bonus.
To report individual measures, you should register for free with MDinteractive. You may need contact MDinteractive in order to setup the appropriate PQRS measures in your account.

Disease / Conditions with PQRS Individual Measures:

Acute Bronchitis
#116. Antibiotic treatment for adults with acute bronchitis - avoidance of inappropriate use

Acute Myocardial Infarction
#28. Aspirin at arrival for acute myocardial infarction (AMI)

Acute Otitis Externa (AOE)
#91. Topical therapy

#92. Pain assessment

#93. Systemic antimicrobial therapy – avoidance of inappropriate use

Anesthesiology and Critical Care
#193. Perioperative temperature management

Asthma
#53. Pharmacologic therapy

#64. Asthma assessment

#231. Tobacco Use: Screening - Ambulatory Care Setting

#232. Tobacco Use: Intervention - Ambulatory Care Setting

Cancer Care
#156. Radiation dose limits to normal tissues

#194. Cancer stage documented

Breast Cancer
#71. Hormonal therapy for stage IC-III, ER/PR positive breast cancer

Chronic Lymphocytic Leukemia
#70. Baseline flow cytometry

Colon Cancer
#72. Chemotherapy for stage III colon cancer patients

Multiple Myeloma
#69. Treatment with bisphosphonates

Myelodysplastic Syndrome
#68. Documentation of iron stores in patients receiving erythropoietin therapy

Myelodysplastic Syndrome & Acute Leukemias
#67. Baseline cytogenetic testing performed on bone marrow

Prostate Cancer
#102. Avoidance of overuse of bone scan for staging low-risk prostate cancer patients

#104. Adjuvant hormonal therapy for high-risk prostate cancer patients

#105. Three-dimensional radiotherapy

Chest Pain (Non-traumatic)
#54. 12-Lead electrocardiogram (ECG) Performed for Non-Traumatic Chest Pain

Chiropractic Care
#182. Functional outcome assessment in chiropractic care

Chronic Kidney Disease (CKD)
#121. Laboratory testing (calcium, phosphorus, intact parathyroid hormone (iPTH) and lipid profile)

#122. Blood pressure management

#123. Plan of care - elevated hemoglobin for patients receiving erythropoiesis-stimulating agents (ESA)

#135. Influenza Immunization

#153. Referral for arteriovenous (AV) fistula

Chronic Obstructive Pulmonary Disease (COPD)
#51. Spirometry evaluation

#52. Bronchodilator therapy

Chronic Wound Care
#186. Use of compression system in patients with venous ulcers

Community-Acquired Bacterial Pneumonia
#56. Vital signs

#57. Assessment of oxygen saturation

#58. Assessment of mental status

#59. Empiric antibiotic

Coronary Artery Bypass Graft (CABG)
#43. Use of internal mammary artery (IMA) in patients with isolated CABG surgery

#44. Preoperative beta-blocker in patients with isolated CABG surgery

Coronary Artery Disease
#06. Oral antiplatelet therapy prescribed for patients with coronary artery disease

#07. Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI)

Measure Description (CMS)

Critical Care
#76. Prevention of catheter-related bloodstream infections (CRBSI) – central venous catheter insertion protocol

Depression & Major Depressive Disorder
#09. Antidepressant medication during acute phase for patients with major depressive disorder

#106. Diagnostic evaluation

#107. Suicide risk assessment

Diabetes Mellitus
#01. Hemoglobin A1c poor control in diabetes mellitus

#02. Low density lipoprotein cholesterol control in diabetes mellitus

#03. High blood pressure control in diabetes mellitus

#117. Dilated eye exam in diabetic patient

#119. Urine screening for microalbumin or medical attention for nephropathy in diabetic patients

#126. Diabetic foot and ankle care, peripheral neuropathy: neurological evaluation

#127. Diabetic foot and ankle care, ulcer prevention: evaluation of footwear

#163. Foot exam

Disorders of the Ear
#188. Referral for Otologic Evaluation for Patients with Congenital or Traumatic Deformity of the Ear

#189. Referral for Otologic Evaluation for Patients with a History of Active Drainage From the Ear Within the Previous 90 Days

#190. Referral for Otologic Evaluation for Patients with a History of Sudden or Rapidly Progressive Hearing Loss

End Stage Renal Disease (ESRD)
#79. Influenza immunization

Endoscopy and Polyp Surveillance
#185. Colonoscopy interval for patients with a history of adenomatous polyps – Avoidance of inappropriate use

Eye Care
Age-Related Macular Degeneration
#14. Dilated macular examination

#140. Counseling on antioxidant supplement

Cataracts
#191. Cataracts: 20/40 or Better visual Acuity within 90 Days Following Cataract Surgery

Measure Description (CMS)

#192. Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures

Measure Description (CMS)

Diabetic Retinopathy
#18. Documentation of presence or absence of macular edema and level of severity of retinopathy

#19. Communication with the physician managing ongoing diabetes care

Primary Open Angle Glaucoma
#12. Optic nerve evaluation

#141. Reduction of intraocular pressure (IOP) by 15% OR documentation of a plan of care

Geriatric Care
#46. Medication reconciliation: Reconciliation after discharge from an inpatient facility

#47. Advance care plan

#181. Elder maltreatment screen and follow-up plan

Falls
#154. Risk assessment

#155. Plan of care

Health Information Technology (Health IT)
#124. Adoption/use of electronic health records (EHR)

Hepatitis C
#83 . Testing for Chronic Hepatitis C – Confirmation of Hepatitis C Viremia

Measure Description (CMS)

#84 . Ribonucleic acid (RNA) testing before initiating treatment

#85. HCV genotype testing prior to treatment

#86. Antiviral treatment prescribed

#87. HCV Ribonucleic acid (RNA) testing at week 12 of treatment

#89. Counseling regarding risk of alcohol consumption

#90. Counseling regarding use of contraception prior to antiviral therapy

#183. Hepatitis A vaccination in patients with HCV

#184. Hepatitis B vaccination in patients with HCV

Ischemic Vascular Disease (IVD)
#201. Blood pressure management control

#202. Complete lipid profile

#203. Low density lipoprotein (LDL-C) control

#204. Use of aspirin or another antithrombotic

Medication Management
#130. Documentation and verification of current medications in the medical record

Nuclear Medicine
#147. Correlation with existing imaging studies for all patients undergoing bone scintigraphy

Osteoarthritis
#109. Function and pain assessment

#142. Assessment for use of anti-inflammatory or analgesic over-the-counter (OTC) medications

Osteoporosis
#24. Communication with the physician managing ongoing care post-fracture

#39. Screening or therapy for osteoporosis for women aged 65 years and older

#40. Management following fracture

#41. Pharmacologic therapy

Otitis Media with Effusion (OME)
#94. Diagnostic evaluation – assessment of tympanic membrane mobility

Pathology
#99 . Breast cancer resection pathology reporting: pT category (primary tumor) and pN category (regional lymph nodes) with histologic grade

#100. Colorectal cancer resection pathology reporting: pT category (primary tumor) and pN category (regional lymph nodes) with histologic grade

Pain Management
#131. Pain assessment prior to initiation of patient therapy and follow-up

Pediatric End Stage Renal Disease (ESRD)
#175. Influenza immunization

Perioperative (Surgical) Care
#20. Timing of antibiotic prophylaxis - Ordering physician

#21. Selection of prophylactic antibiotic - First OR second generation cephalosporin

#22. Discontinuation of prophylactic antibiotics (Non-cardiac procedures)

#23. Venous thromboembolism (VTE) prophylaxis (When indicated in ALL patients)

#30. Timing of prophylactic antibiotics - Administering physician

#45. Discontinuation of prophylactic antibiotics (Cardiac procedures)

#157. Recording of clinical stage for lung cancer and esophageal cancer resection

#158. Use of patch during conventional endarterectomy

# 172. Hemodialysis vascular access decision-making by surgeon to maximize placement of autogenous arterial venous (AV) fistula

Pharyngitis
#66. Appropriate testing for children with pharyngitis

Preventive Care and Screening
#110. Influenza immunization for patients ≥ 50 years old

#111. Pneumonia vaccination for patients 65 years and older

#112. Screening mammography

#113. Colorectal cancer screening

#226. Tobacco Use: Screening and Cessation Intervention

#128. Body mass index (BMI) screening and follow-up

#134. Screening for clinical depression and follow-up plan

#173. Unhealthy alcohol use - screening

Radiology
#10. Computed tomography (CT) or magnetic resonance imaging (MRI) reports

#145. Exposure time reported for procedures using fluoroscopy

#146. Inappropriate use of "probably benign" assessment category in mammography screening

#195. Stenosis measurement in carotid imaging reports

#225. Reminder System for Mammograms

Rheumatoid Arthritis
#108. Disease modifying anti-rheumatic drug (DMARD) therapy

#176. Tuberculosis screening

#177. Periodic assessment of disease activity

#178. Functional status assessment

#179. Assessment and classification of disease prognosis

#180. Glucocorticoid management

Stroke and Stroke Rehabilitation
#31. Deep vein thrombosis (DVT) prophylaxis for ischemic stroke or intracranial hemorrhage

#32. Discharged on antiplatelet therapy

#33: Anticoagulant Therapy Prescribed for Atrial Fibrillation at Discharge

Measure Description (CMS)
Data Collection Sheet

#35. Screening for dysphagia

#36. Consideration of rehabilitation services

Syncope
#55. 12 Lead electrocardiogram performed for syncope

Upper Respiratory Infection (URI)
#65. Treatment for children with upper respiratory infection - avoidance of inappropriate use

Urinary Incontinence
#48. Assessment of presence or absence of urinary incontinence in women aged 65 years and older

#49. Characterization of urinary incontinence in women aged 65 years and older

#50. Plan of care for urinary incontinence in women aged 65 years and older

Melanoma
#224: Melanoma: Overutilization of Imaging Studies in Stage 0-IA

Measure Description (CMS)

#137: Melanoma: Continuity of Care – Recall System

Measure Description (CMS)

#138: Melanoma: Coordination of Care

Measure Description (CMS)

Oncology: Medical and Radiation
#143: Pain Intensity Quantified

Measure Description (CMS)

#144: Plan of Care for Pain

Measure Description (CMS)

PQRS Individual Quality Measures

PQRS Registries